Trending...
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide - 109
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide - 107
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media - 106
Gold Standard Diagnostics receives FDA clearance for AIX1000® 2.1-- now with extra high titer capabilites.
DAVIS, Calif. - Californer -- Gold Standard Diagnostics Launches AIX1000 2.1® with Extra High Titer RPR Testing and Enhanced Workflow Features
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on The Californer
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
The AIX1000® 2.1 software is fully compatible with:
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on The Californer
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on The Californer
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- IEI Introduces HTB-300-MTL-H: Ultra-Compact Medical AI Embedded System
- Mesa West Capital Funds $30 MM Loan for Acquisition of Industrial Asset in San Francisco Bay Area
- 40th Annual California Strawberry Festival Accepting Applications for Arts & Crafts Vendors
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
- Reflex Runs After Worklist Completion
- Automatic Next Actions
- Improved LIS Communication – Easier for LIS systems to interpret run data
- Enhanced Data Analysis
- Faster Backup and Restore
- Bleach Maintenance Support – Compatible with the GSD Bleach (Cat # SHW-20)
- Optional Text and Email Notifications for Errors
The AIX1000® 2.1 software is fully compatible with:
- Gold Standard Diagnostics Rapid Plasma Reagin (RPR) Test System (Cat # GSD01-1600)
- GSD Bleach (Cat # SHW-20)
- GSD RPR Diluent (Cat # GSD01-1600-DIL)
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on The Californer
- Play with Purpose: Meemzy Magic Sensory Kits Support Child Development in a Fun Format
- California: Governor Newsom announces top former CDC officials to lead public health innovation, collaboration
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- Celebrate Festively with Christmas Eyeglasses
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Source: Gold Standard Diagnostics, LLC
Filed Under: Biotech
0 Comments
Latest on The Californer
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- The Iconic Cops TV Show Is Now Streaming on AwepraTV
- Matt Ox Releases New Visual Content Highlighting Artistic Growth and Collaboration
- Silva Construction Unveils 2026 Design Trends
- California: Governor Newsom announces appointments 12.12.2025
- Interpreters Unlimited Helps NORAD Track Santa in More Languages Than Ever Before
- Quantum Capital Partners Secures $26M Construction Financing to Kickstart Major Mixed-Use Activation
- City of Long Beach Announces Awardees for Love Your Block Mini-Grant Program
- Updated EasyDesktop 10 organizer is the answer to time-wasting icon overload
- Long Beach Parks, Recreation and Marine Older Adult Program Returns to Expo Arts Center
- TIME's Person of the Year was Made in California
- Stay Connected Cell Service Optional
- Ventura College Foundation Distributes Record $1.16 Million in Direct Student Support
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- 'A Hot Set' Launches New Feature: The Best and Worst of Soap Operas
- The Best Cartier-Inspired Jewellery to Buy in 2025 — Just in Time for the Ermoleve Christmas Sale
- No Tipping Car Wash in Northridge CA
- California state parks are for everyone, while Trump turns national parks into his vanity project
- California: Trump's AI executive order advances corruption, not innovation